We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Smart Nanoparticles Designed to Identify, Target, and Kill Cancer Cells

By LabMedica International staff writers
Posted on 07 Apr 2010
Nanoparticles have been designed that can identify, target, and destroy specific cancer cells while leaving healthy cells alone.

Led by Dr. More...
Carl Batt, a professor of food science at Cornell University (Ithaca, NY, USA), the researchers synthesized nanoparticles--shaped similar to a dumbbell --made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers used a near-infrared laser, which is a wavelength that does not harm normal tissue at the levels utilized, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die. "This is a so-called ‘smart' therapy,” Dr. Batt said. "To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it's there and then kills just the cancer cells.”

The goal, according to lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells. "If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed--that is the critical thing,” Mr. Kirui said.

Gold has potential as a material key to combating cancer in future smart therapies. It is biocompatible, inert, and comparatively easy to modify chemically. By changing the size and shape of the gold particle, the investigators can tune them to respond to different wavelengths of energy.

Once taken up by the researchers' gold particles, the cancer cells are destroyed by heat--just a few degrees above normal body temperature--while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that specific wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide, which is essentially rust, as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Mr. Kirui noted, by taking advantage of the particles' magnetic properties.

The research was published in the February 15, 2010, online edition of the journal Nanotechnology.

Related Links:

Cornell University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.